Associations between two lactoferrin-targeting SOMAmers and classical AD biomarkers, including total tau (t-tau), phosphorylated tau (p-tau181), and amyloid-beta 42 (Aβ42), were assessed. This evidence concerns the gene LTF and Alzheimer disease.